Injection Safety · FDA Label–Verified · 2026
GLP-1 Injection Mistakes to Avoid — and Exactly What to Do When You've Made One
Bottom line
Most GLP-1 injection mistakes are small. The ones with real label-verified safety risk cluster in a tight group — drawing the wrong dose from a compounded vial, taking doses too close together or doubling up after a shot felt off, using a pen or vial the label says to throw away, and restarting at maintenance dose after missing two or more weeks. Site rotation, cold injection, and not pinching skin affect comfort, not safety. This guide ranks every common mistake by what actually causes harm and gives you the exact fix for each one.
Pick what just happened — fast triage
If you're reading this five minutes after an injection that didn't go the way you expected, jump straight to the section that fits:
- 💧Medicine leaked out, or you saw a stream from the needle
- ⚠️You took a second shot because the first felt off
- 📅You missed your dose
- 🌡️Your pen got left out, in a hot car, or in the freezer
- 🧪You're using a compounded vial and you're not sure if the units are right
- 🏥You're feeling sick after a shot and don't know if it's normal
- ✅You haven't injected yet and you want a checklist for the first one
Severe symptoms after a dose mistake?
Call Poison Help at 1-800-222-1222 or seek emergency care. Free, 24/7, staffed by trained nurses, pharmacists, and doctors. Per HRSA, callers speak directly with a clinical professional at their local poison center.
Which GLP-1 products this guide covers
This guide does not cover Byetta, Bydureon BCise, Victoza, Adlyxin, Soliqua, Xultophy, or oral products (Rybelsus, Wegovy tablets). Check your specific Medication Guide before applying any rule from this page to those products.
The 13 GLP-1 injection mistakes to avoid — ranked by what actually hurts you
This is an editorial risk tier — not a clinical trial finding. Built from three source buckets: FDA-documented compounded-GLP-1 dosing errors and adverse-event reports, FDA-approved label warnings, and Poison Centers exposure patterns.
| Tier | What it is | Why it's at this tier |
|---|---|---|
| Tier 1 — High risk |
| FDA-documented dosing errors and hospitalizations; label-mandated discard rules; hypoglycemia risk with combination therapy |
| Tier 2 — Medium risk |
| Reduced effectiveness, worse side effects, infection risk, unpredictable absorption |
| Tier 3 — Comfort / minor |
| Affects comfort or absorption modestly, not safety |
Mistake 1: Drawing the wrong dose from a compounded vial — the FDA's GLP-1 dosing-error alert
Compounded GLP-1s come from compounding pharmacies — facilities that mix custom medications. They are not FDA-approved and the concentration printed on the vial can vary between refills and between pharmacies. That's where the danger lives.
The prescribed dose is in milligrams, the vial is labeled in milligrams per milliliter, and the insulin syringe is marked in "units." Three different units of measurement that don't translate to each other without the specific concentration of the vial in your hand. If the concentration changes between refills — and it often does — the same number of units delivers a different amount of medication. The FDA documented some patients drawing 50 units when their prescriber meant 5 — a tenfold overdose.
How to actually fix this
Read these two lines off your vial label every single time, before every injection:
The medication and concentration — e.g., "semaglutide 5 mg/mL" or "tirzepatide 17 mg/mL."
The exact units to draw for your prescribed dose — must match the chart your dispensing pharmacy gave you for this specific vial.
Mistake 2: Using a pen or vial the label says to throw away
Every manufacturer says the same thing: discard if frozen, even after thawing. Visible particles or discoloration is also a discard trigger across all labels.
What to look at before every shot
Mistake 3: Injecting into a muscle when you're also on insulin or a sulfonylurea
How to make sure you're hitting fat, not muscle
- 1Use the abdomen, the front of the thigh, or the back of the upper arm. Avoid the inner thigh, buttocks, and any area where you can't easily feel a soft layer of subcutaneous fat.
- 2For people on the leaner side, pinch the skin gently. Lift a fold and inject into the fold at a 90-degree angle. The fold puts the fatty tissue between you and the muscle.
- 3For people with more abdominal fat, no pinch needed for a standard short pen needle.
- 4Inject straight in (90 degrees), not at an angle, unless your provider specifically taught you a different technique for a thinner site.
Mistake 4: Taking a second shot because the first one "felt wrong"
GLP-1 overdoses produce predictable symptoms: severe nausea, severe vomiting, severe diarrhea, dehydration, and in people on insulin or a sulfonylurea, hypoglycemia. Semaglutide has a half-life of about 7 days; tirzepatide roughly 5 days — the effects of an overdose can last for a week or more.
Device completion cues — check this first
Then write down what happened, and call
Document: medication name, time of injection, what the device did, what symptoms you have, how much liquid (if any) you saw on your skin. Take a photo of the pen if it might be defective.
Wegovy
1-833-934-6891
Novo Nordisk
Ozempic
1-866-696-4090
Novo Nordisk
Saxenda
1-844-845-6913
Novo Nordisk
Mounjaro · Zepbound · Trulicity
1-800-545-5979
Eli Lilly (1-800-LILLYRX)
Do not inject a second dose unless they tell you to.
The full GLP-1 storage and missed-dose chart
Built from FDA labels via DailyMed and manufacturer IFUs. Last verified May 7, 2026. GLP-1 storage and missed-dose rules are not interchangeable across brands — using the wrong brand's rule is Tier 2 mistake #7.
| Medication | Active ingredient | Schedule | Refrigerated storage | Room-temp limit | Once at room temp | Missed-dose rule | Source |
|---|---|---|---|---|---|---|---|
| Wegovy single-dose pen (incl. HD 7.2 mg) | semaglutide | Weekly | 36–46°F (2–8°C) until expiration | Up to 86°F for 28 days total, before cap removal, in original carton | May return to refrigerator within the 28-day total | Next dose >48 hrs away → take it. <48 hrs → skip. 2+ doses missed → resume on schedule or reinitiate dose escalation. | DailyMed Wegovy label; Wegovy IFU |
| Ozempic multi-dose pen | semaglutide | Weekly | 36–46°F until first use | After first use: 56 days at 59–86°F (15–30°C) or refrigerated | After first use, may store at room temperature or refrigerated for the 56-day in-use window | Within 5 days of scheduled dose → take it. After 5 days → skip. | DailyMed Ozempic label |
| Mounjaro / Zepbound single-dose pen or vial⚠ See callout below | tirzepatide | Weekly | 36–46°F until expiration | Up to 86°F for a total of 21 days — discard after 21-day total, even if put back in fridge | Refrigerating again does not reset the 21-day total | Within 4 days (96 hrs). Do not take 2 doses within 3 days. | DailyMed Mounjaro / Zepbound label |
| Mounjaro / Zepbound multi-dose vial or KwikPen | tirzepatide | Weekly | 36–46°F until first use | After first use: 30 days at room temp or refrigerated. Discard after 30-day total, 30 days after first use, or after 4 weekly doses — whichever comes first | Refrigerating does not reset the 30-day total | Within 4 days (96 hrs). Do not take 2 doses within 3 days. | DailyMed Mounjaro / Zepbound multi-dose label |
| Trulicity single-dose pen⚠ See callout below | dulaglutide | Weekly | 36–46°F until expiration | Up to 86°F for a total of 14 days — shortest of all products covered here | Refrigerating does not reset the 14-day total | Take if ≥3 days (72 hrs) remain before next dose. Otherwise skip. | DailyMed Trulicity label |
| Saxenda multi-dose pen | liraglutide | Daily | 36–46°F until first use | After first use: up to 86°F for 30 days, or refrigerated | After first use, may store at room temp or refrigerated for the 30-day in-use window | Resume next scheduled daily dose; no extra dose. If >3 days lapsed, restart at 0.6 mg daily and re-escalate per label/prescriber. | DailyMed Saxenda label |
| Compounded semaglutide / tirzepatide vial | varies | Per prescriber | Per pharmacy label (typically 36–46°F) | Per pharmacy beyond-use date | Per pharmacy | Per prescriber's schedule (no FDA-uniform rule — not FDA-approved) | FDA: Concerns with Unapproved GLP-1 Drugs |
Wegovy gets 28 days at room temperature. Mounjaro and Zepbound single-dose pens get 21. If you switched from Wegovy to Zepbound and you're still using the 28-day rule, you could be using a pen that's a week past its safe room-temperature window.
For Mounjaro, Zepbound, and Trulicity, the room-temperature window is a total clock. Putting the pen back in the fridge does not reset the count. Total time at room temperature must stay under 21 days (Mounjaro/Zepbound single-dose), 30 days (Mounjaro/Zepbound multi-dose), or 14 days (Trulicity).
Trulicity has a 14-day room-temperature limit — the shortest of the products covered here. People assume "all GLP-1s are 21 or 28 days." Trulicity isn't.
Ozempic's 56-day in-use rule is unique. Once you start it, you have 56 days — whether stored at room temperature or refrigerated — before you must throw it away, even if medication remains.
Saxenda is daily, not weekly. Different missed-dose math entirely.
Compounded products follow no uniform FDA rule. Whatever your pharmacy printed on the label is the rule.
What to do if your medicine leaked or the pen seemed to misfire
| Product | What to check | What it means |
|---|---|---|
| Wegovy | The yellow bar in the medication window | Dose finished when the yellow bar stops moving. If you removed the pen before the bar finished, some dose was lost. |
| Ozempic | Dose counter and 6-second hold | Dose finished when counter shows "0" and you hold needle in skin for six seconds. A stream on your skin after withdrawal means you pulled too early. |
| Trulicity | Two clicks (start and finish) | Dose finished when the second click happens, about 5–10 seconds after the first. One click = incomplete. |
| Mounjaro / Zepbound single-dose pen | The gray plunger | Dose finished when the gray plunger is visible at the bottom of the medication window. No gray plunger = call Lilly. |
| Saxenda | Dose counter (not the clicks) | Dose finished when counter returns to 0 and you've counted slowly to 6 with needle in skin. IFU warns specifically against counting clicks. |
| Compounded vial / insulin syringe | Plunger and barrel | Dose finished when plunger is fully seated and barrel is empty. Liquid still in barrel = incomplete. |
Small drop of blood at the site
You hit a tiny surface vessel — normal. Press lightly with gauze or cotton; do not rub. The dose still went in.
Small drop of medication on your skin
A small amount of dose was lost. Don't try to estimate how much. Note it in your records and use the full hold time on your next injection.
When to call
- The dose counter or completion indicator didn't behave as expected
- The pen feels jammed, the needle looks bent, or the device looks visibly damaged
- You see a large stream of liquid on your skin after withdrawing
- You're not sure how much dose you got — especially if you're considering injecting again
What to do if you accidentally took two doses
Don't panic
A doubled GLP-1 dose is uncomfortable, but for most people without other risk factors it's manageable with monitoring.
Hydrate aggressively
Sip water and electrolytes throughout the day. Severe vomiting and diarrhea cause dehydration faster than people expect.
Check your blood sugar more often than usual
If you're also on insulin, a sulfonylurea, or any other diabetes medication. Hypoglycemia is the hidden danger.
Call your prescriber's office
Tell them what happened, what you took, when, and what symptoms you have.
Watch for severe symptoms
Severe abdominal pain that radiates to your back (possible pancreatitis), persistent vomiting, signs of dehydration, fainting, or low blood sugar that doesn't respond to fast-acting sugar — any of these means you need to be seen urgently.
Call Poison Help (1-800-222-1222) or go to the ER if symptoms escalate
Per America's Poison Centers, GLP-1 mistakes including taking doses too close together or higher than the recommended amount are routinely handled by Poison Help.
What not to do
- Don't fast or skip food — empty stomach plus extra GLP-1 is a recipe for worse nausea
- Don't take more medication
- Don't take your next scheduled dose without calling your prescriber to figure out the correct restart timing
- Don't crowdsource a treatment plan from social media
What to do if you missed a dose — rules differ by brand
| Medication | If you remember within… | What to do | Source |
|---|---|---|---|
| Wegovy | Next dose >48 hours away | Take the missed dose now. Resume schedule. | DailyMed Wegovy label |
| Wegovy | Next dose <48 hours away | Skip. Take next dose on schedule. | DailyMed Wegovy label |
| Ozempic | 5 days of scheduled dose | Take it now. Resume regular schedule. | DailyMed Ozempic label |
| Ozempic | More than 5 days | Skip. Take next dose on regular day. | DailyMed Ozempic label |
| Mounjaro / Zepbound | 4 days (96 hours) of scheduled dose | Take it now. Then wait at least 3 days before next dose. | DailyMed Mounjaro / Zepbound label |
| Mounjaro / Zepbound | More than 4 days | Skip. Take next dose on regular day. | DailyMed Mounjaro / Zepbound label |
| Trulicity | At least 3 days (72 hours) before next dose | Take the missed dose. | DailyMed Trulicity label |
| Trulicity | Less than 3 days before next dose | Skip. | DailyMed Trulicity label |
| Saxenda (daily) | Same day or next | Resume the once-daily regimen with the next scheduled dose. Do not take extra dose. | DailyMed Saxenda label |
| Saxenda (daily) | More than 3 days lapsed | Restart at 0.6 mg daily and re-escalate per label. Call prescriber. | DailyMed Saxenda label |
Where to inject — and how to actually rotate sites
The quadrant method — the actually useful version of "rotate sites"
Divide your abdomen into four quadrants — like four squares around your belly button (avoiding the 2-inch radius around the belly button, per the Wegovy IFU).
Then go back to quadrant one — but at least an inch or two from where you injected four weeks ago. This gives every spot at least four weeks to recover. The same principle applies if you alternate between abdomen, thigh, and arm — the unit you're rotating is the spot, not the body region.
Where not to inject
- Within 2 inches of the belly button (per Wegovy IFU — reasonable rule for any abdominal injection)
- Bruised, red, hard, swollen, tender, scarred, or stretch-marked skin
- Any visible lump (lipohypertrophy)
- The buttocks (not approved for any GLP-1 — that's for IM injections)
- The inner thigh (less consistent fat layer, more variable absorption)
The pre-injection checklist we wish every prescriber handed out
Confirm
- ☐Wash your hands
- ☐Confirm the medication name on the label matches your prescription
- ☐Confirm the dose strength matches what your prescriber wrote
- ☐Confirm today is your scheduled injection day
- ☐Check the expiration date on the carton and on the pen
- ☐If using a compounded vial: confirm the concentration printed on this specific vial matches the dose chart from your dispensing pharmacy
Inspect the solution
- ☐Hold the pen up to a light and look through the medication window
- ☐Solution is clear and colorless (or very slightly yellow, depending on brand)
- ☐No cloudiness, particles, or discoloration
- ☐No signs the medication has been frozen
- ☐If anything looks off — throw the pen out and use a new one
Prepare the device
- ☐Attach a new needle (for multi-dose pens that require it, like Ozempic and Saxenda)
- ☐For a brand-new pen: do the priming or flow check the IFU specifies before the first injection
- ☐Set the dose, if your pen has a dose dial
- ☐Confirm the dose counter shows the prescribed amount
Inject
- ☐Choose a clean, unlumped injection site in your weekly rotation
- ☐Wipe the skin with an alcohol swab and let it dry fully (injecting through wet alcohol stings)
- ☐Pinch the skin gently if you're thinner; skip the pinch if you have more abdominal fat
- ☐Insert the needle straight in (90 degrees) and press the dose button
- ☐Hold for the required time per your device's completion indicator
- ☐Withdraw the needle slowly
Document and dispose
- ☐Write down date, time, dose, site, and any notes
- ☐Drop the used needle (or the whole single-dose pen) into an FDA-cleared sharps container immediately
- ☐Set your reminder for next week's injection
Sharps and needles — the rules nobody told you
Use
- FDA-cleared sharps disposal container (puncture-resistant, leak-proof, labeled)
- When FDA-cleared container unavailable: heavy-duty plastic household container with tight, puncture-resistant lid, labeled "USED SHARPS — DO NOT RECYCLE"
Never use
- Soda bottles (too thin)
- Glass jars (break easily)
- Coffee cans (rust and leak)
- Plastic shopping bags (no puncture resistance)
Where to take the full container
- Drop-off at a participating pharmacy or hospital
- Mail-back program (some manufacturers offer one)
- Hazardous-waste collection day in your community
- State household sharps program — check your state health department
Counterfeit and "research-use" GLP-1s — the unsafe shortcut
How to know what you're getting
- A real prescription from a real prescriber
- A state-licensed pharmacy (you can verify with the state board of pharmacy)
- Medication that arrives sealed, with manufacturer labeling, in temperature-controlled packaging
- A pharmacist you can call with questions
If any of those four are missing, you're taking a different kind of risk than the one this guide can fix.
When to call for help — and which number
Call your prescriber
- Side effects interfering with your life but not severe
- A dose mistake where you're not sure what to do next
- Any new symptom you're not sure about
- A device that's behaving oddly
Call the manufacturer
Call Poison Help — 1-800-222-1222
- Confirmed or suspected overdose
- Severe symptoms after a dose mistake — especially severe vomiting, dehydration, hypoglycemia, or fainting
- You need a clinical professional on the phone right now and your prescriber's office is closed
Free, 24/7. Per HRSA, callers speak with a specially trained nurse, pharmacist, or doctor at their local poison center.
Go to the ER
- Severe abdominal pain that radiates to the back (possible pancreatitis)
- Persistent vomiting that won't stop
- Hypoglycemia symptoms that don't resolve with fast-acting sugar
- Difficulty breathing, swelling of the face/lips/tongue, or hives (possible allergic reaction)
- Signs of severe dehydration (dizziness on standing, very low urine output, confusion)
- Fainting
When your provider is part of the problem
Sign #1: No titration plan in writing
Every FDA-approved GLP-1 has a step-up dosing schedule. If your provider started you at maintenance dose to "speed up results," or didn't write down what week you should move from one dose to the next, that's not aggressive medicine. It's a clinical red flag.
Sign #2: Compounded vial without a printed concentration sheet
If your dispensing pharmacy didn't give you a printed page that says "your vial is X mg/mL, draw Y units on the syringe we sent to get Z mg," you are doing the math without a checked source.
Sign #3: Can't get a pharmacist or clinician on the phone reasonably quickly
If you're holding a vial you're not sure about and there's no one to call, the safety system has failed.
What a good GLP-1 provider does
- Provides a written titration plan that covers every dose for the next 16 weeks
- For compounded medications, sends a printed concentration sheet with every refill, plus a syringe sized to the dose
- Has a real phone number that gets answered by a pharmacist or clinician promptly
- Re-titrates after missed weeks instead of resuming at maintenance
- Doesn't gate-keep anti-nausea support or charge it as an upsell
FDA-approved GLP-1 + insurance navigation
Ro
Integrates with manufacturer patient programs for Wegovy, Ozempic, Zepbound, and Mounjaro. Runs a structured titration protocol. Free GLP-1 insurance coverage check.
Check GLP-1 Access on Ro →Cash-pay transparent pricing
Sesame Care
Transparent cash pricing for office visits and prescriptions when insurance doesn't cover the brand. Multiple clinician options on one marketplace.
Browse GLP-1 Providers on Sesame →We have not independently audited their compliance with every item on the safety checklist above. Run the checklist yourself before signing up with any provider — including the ones we work with.
Frequently Asked Questions
What we actually verified
Primary sources
- •FDA prescribing information and IFUs for Wegovy (incl. Wegovy HD 7.2 mg, FDA-approved March 19, 2026) via DailyMed
- •FDA prescribing information and IFUs for Ozempic, Mounjaro, Zepbound (single-dose pens, single-dose vials, multi-dose vials, and KwikPens), Trulicity, and Saxenda via DailyMed
- •Manufacturer IFUs on wegovy.com, ozempic.com, saxenda.com, mounjaro.com, zepbound.com, and trulicity.com
- •FDA "Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" page
- •FDA dosing-error safety communication on compounded injectable semaglutide products (originally published July 26, 2024)
- •FDA "Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize" statement
- •FDA proposal (April 30, 2026) regarding semaglutide, tirzepatide, and liraglutide on the 503B bulks list
- •CDC injection safety guidance ("One Needle, One Syringe, Only One Time")
- •FDA sharps disposal guidance
- •America's Poison Centers GLP-1 page
- •HRSA Poison Help description
What we did not do
- • We did not run a clinical trial.
- • We did not add a "medically reviewed by Dr. ___" badge — no individual clinician has signed off on the clinical content. The Tier 1 / Tier 2 / Tier 3 risk ranking is our editorial conclusion based on the three source buckets above. It is not a clinical trial finding.
- • We did not pretend to have access to data we don't have.
Refresh schedule
Quarterly review. We re-check every FDA label, every storage rule, the FDA's compounded-GLP-1 enforcement status, and the manufacturer support numbers every three months — plus immediately after any major FDA safety communication. The "last verified" date at the top of this page updates when we recheck.
The shortest possible summary
Most GLP-1 injection mistakes don't matter much. The ones that do cluster in a small group: wrong dose from a compounded vial, frozen or out-of-storage pen, hitting muscle while on insulin or a sulfonylurea, and double-dosing because the first shot felt off. The fix for the dangerous mistakes is the same in every case: stop, don't inject again on assumption, check the pen's completion indicator, and call your prescriber, your pharmacist, the manufacturer, or Poison Help (1-800-222-1222) before you do anything else. The chart in this guide tells you the storage and missed-dose rule for the six FDA-approved injectable GLP-1s most people are searching about, plus compounded products. Bookmark it. The mistakes are predictable. The fixes are simple. The hardest part is the part where you don't panic and inject again.
Last verified May 7, 2026, against current FDA and DailyMed prescribing information and IFUs for Wegovy, Ozempic, Zepbound, Mounjaro, Trulicity, and Saxenda. Provider policies, FDA label language, and support numbers change. Re-verify monthly for drug-specific rules.
This page contains affiliate links. If you purchase through them, we may earn a commission at no extra cost to you. Clinical guidance is based on the FDA labels and authoritative sources cited above, not on commercial relationships.
This page is for general informational purposes and does not constitute medical advice. GLP-1 medications are prescription treatments. Consult your healthcare provider and pharmacist before making any clinical decisions based on this content.